CFOs Concerned about Rising Health Costs

Chief financial officers are worried about the increasing volatility of health care expenses, including the potential impact of GLP-1 drugs, according to data from Mercer.
Share This Post
Related Articles
Receive the latest updates

Subscribe To
Our Quarterly Newsletter

Get notified about new blog posts, case studies, white papers, and more!